Literature DB >> 18559925

EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.

Leah J Anderson1, Richard Longnecker1.   

Abstract

Latent membrane protein 2A (LMP2A) of Epstein-Barr virus (EBV) provides developmental and survival signals that mimic those of a B-cell receptor (BCR). Expression of LMP2A during B-cell development results in the ability of B cells to exit the bone marrow in the absence of a BCR and persist in the periphery, where they would normally undergo apoptosis. This study extends the current knowledge of LMP2A function by examining the growth properties of bone marrow B cells from TgE LMP2A mice. Despite the lack of pre-BCR expression, bone marrow B cells from TgE LMP2A mice proliferate and survive in low concentrations of interleukin 7, similar to wild-type cells. Constitutive phosphorylation of ERK/MAPK and PI3K/Akt in TgE LMP2A bone marrow B cells is also reminiscent of signalling through the pre-BCR, altogether demonstrating that LMP2A provides a pre-BCR-like signal to developing B cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559925      PMCID: PMC2841786          DOI: 10.1099/vir.0.2008/001461-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  45 in total

Review 1.  ITAM-mediated tonic signalling through pre-BCR and BCR complexes.

Authors:  John G Monroe
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

2.  Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Authors:  R G Caldwell; J B Wilson; S J Anderson; R Longnecker
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

3.  Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.

Authors:  R G Caldwell; R C Brown; R Longnecker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation.

Authors:  Makoto Fukuda; Richard Longnecker
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.

Authors:  C L Miller; A L Burkhardt; J H Lee; B Stealey; R Longnecker; J B Bolen; E Kieff
Journal:  Immunity       Date:  1995-02       Impact factor: 31.745

6.  The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction.

Authors:  S Fruehling; R Longnecker
Journal:  Virology       Date:  1997-09-01       Impact factor: 3.616

7.  Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway.

Authors:  H E Fleming; C J Paige
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

8.  Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.

Authors:  Michelle A Swanson-Mungerson; Robert G Caldwell; Rebecca Bultema; Richard Longnecker
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.

Authors:  J A Morrison; A J Klingelhutz; N Raab-Traub
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  The immunoglobulin (Ig)alpha and Igbeta cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice.

Authors:  Y M Teh; M S Neuberger
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

View more
  23 in total

Review 1.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

2.  A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma.

Authors:  Kathryn T Bieging; Kamonwan Fish; Subbarao Bondada; Richard Longnecker
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

Review 3.  Autoimmunity checkpoints as therapeutic targets in B cell malignancies.

Authors:  Markus Müschen
Journal:  Nat Rev Cancer       Date:  2018-01-05       Impact factor: 60.716

4.  Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.

Authors:  Sugalesini Subramaniam; John Johnston; Likit Preeyanon; C Titus Brown; Hsing-Jien Kung; Hans H Cheng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

5.  Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.

Authors:  Leah J Anderson; Richard Longnecker
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

Review 6.  Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.

Authors:  Fang Wei; Qing Zhu; Ling Ding; Qing Liang; Qiliang Cai
Journal:  Virol Sin       Date:  2016-09-12       Impact factor: 4.327

7.  Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis.

Authors:  R Bultema; R Longnecker; M Swanson-Mungerson
Journal:  Oncogene       Date:  2009-02-02       Impact factor: 9.867

8.  Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.

Authors:  Ryan Incrocci; Samira Hussain; Amanda Stone; Kathryn Bieging; Lauren A C Alt; Michael J Fay; Michelle Swanson-Mungerson
Journal:  Cell Immunol       Date:  2015-08-04       Impact factor: 4.868

9.  Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

Authors:  Kathryn T Bieging; Alexandra C Amick; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

10.  Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development.

Authors:  Malay Mandal; Sarah E Powers; Kyoko Ochiai; Katia Georgopoulos; Barbara L Kee; Harinder Singh; Marcus R Clark
Journal:  Nat Immunol       Date:  2009-09-06       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.